
CAC2 Childhood Cancer Community News Digest (September 4-10)
Assorted News from the Last Week: A retrospective study shows that more intense ALL therapy improves outcomes in adolescents and young adults. This treatment option
Assorted News from the Last Week: A retrospective study shows that more intense ALL therapy improves outcomes in adolescents and young adults. This treatment option
Assorted News from the Last Week: Major League Soccer, MLS WORKS – the League’s social responsibility platform – and Continental Tire are teaming up during
Assorted News from the Last Week: Despite major advances in cancer research, we collectively fall short in bringing innovative medicines to children with cancer. A
Assorted News from the Last Two Weeks: Latino children are at greater risk of developing certain cancers, and their short and long-term outcomes are often
Assorted News from the Last Week: High-Throughput drug screening of primary tumor cells identifies therapeutic strategies for treating children with high-risk cancer. Tribute to CAC2
Assorted News from the Last Week: The Senate Appropriations Committee has released its Fiscal Year 2024 Labor-HHS Appropriations bill, and we are excited to report that
Assorted News from the Last Week: A Danish study shows that five-year survival of all children with acute lymphatic leukemia (ALL) has continued to increase
Assorted News from the Last Week: From the Journal of the National Cancer Institute: “the annual rate of pediatric cancer has declined from a peak
Assorted News from the Last Week: Sub-Saharan Africa is facing a childhood cancer crisis. Annually, nearly 90% of the more than 100 000 children who develop
Assorted News from the Last Week: Yoram Unguru (past CAC2 Summit speaker, bioethicist, and uncle of a pediatric cancer survivor) on the cancer drug shortage.